Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05096910
Other study ID # 10840098-772.02-E.43598
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 4, 2020
Est. completion date January 1, 2022

Study information

Verified date October 2021
Source Uludag University
Contact Kiper Aslan, M.D.
Phone +905548127272
Email kiperaslan@yahoo.com.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This multicenter prospective randomized controlled trial aims to investigate the ishtmocele rates after c-section delivery depending on using different suture materials for the uterine closure.


Description:

The study involves 5 health centers (two universities, three private hospitals). Patients who will undergo their first cesarean section because of any etiology (except emergent cases) will be included in the study. Operation Nurse will randomize the patients into two groups depending on the monofilament or poly filament suture material. Patients will be checked by transvaginal ultrasound on a postoperative day one, postoperative first month, and postoperative sixth month. As the primary result, the istmocele rates will be compared between the study groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date January 1, 2022
Est. primary completion date January 1, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - 18-40 yrs women - Primary elective cesarean section - First delivery - Without any systemic diseases Exclusion Criteria: - emergent delivery - previous c-section history - congenital uterine abnormality

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Uterine Closure with monofilament or polyfilament suture materials
Postoperative 6th-month isthmocele rates

Locations

Country Name City State
Turkey Uludag University Scholl of medicine Bursa Turkey/bursa

Sponsors (4)

Lead Sponsor Collaborator
Uludag University Bursa Medicana Hospital, Ceylan Hospital, UMI Health Center

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Isthmocele Rate diagnosis of isthmocele during 6th month ultrasound check. 6 months
See also
  Status Clinical Trial Phase
Withdrawn NCT02968459 - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars Phase 2
Completed NCT03676907 - Assessment of Single and Double Layer Suturation of Lower Segment Uterine Incision by USG After C/S N/A
Withdrawn NCT03181087 - Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars Phase 1
Completed NCT03629028 - Single or Double-layer Uterine Closure Techniques N/A